This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Nestec S.a., L'oreal. Active years: 2012-2015.
Company Filing History:
5 out of 2,371 
1 out of 5,226 
Years Active: 2012-2015
Title: David Philippe: Innovator in Obesity and Inflammation Treatments
Introduction
David Philippe is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the fields of obesity and inflammation through his innovative research and patents. With a total of five patents to his name, Philippe is recognized for his dedication to improving health outcomes.
Latest Patents
Among his latest patents, one invention focuses on the use of probiotics to treat obesity. This invention highlights the potential of specific strains, such as CGMCC 1.3724 and NCC 4007, in creating compositions that support weight management and promote weight loss. Another significant patent addresses inflammation, utilizing natural compounds like wolfberries to develop products aimed at treating or preventing inflammatory conditions. These inventions showcase Philippe's commitment to leveraging natural solutions for health challenges.
Career Highlights
Throughout his career, David Philippe has worked with prominent companies, including Nestec S.A. and L'Oréal. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in health and wellness.
Collaborations
Philippe has collaborated with notable colleagues, including Catherine Mace and Fabrizio Arigoni. These partnerships have further enriched his research and development efforts, leading to impactful innovations.
Conclusion
David Philippe stands out as an inventor dedicated to addressing critical health issues through his innovative patents. His work in obesity and inflammation exemplifies the potential of scientific research to create meaningful solutions for society.